For now, the is available for early-access partnerships. Sponsors who adopt the beta can expect a 40% reduction in data cleaning time before database lock (DBL). Conclusion: Is the iKey Prime Beta 0900 New Right for Your Next Trial? If you are managing a decentralized clinical trial (DCT) , a rare disease study requiring intensive home monitoring, or a Phase 3 cardiometabolic trial with thousands of data points per patient per day, the answer is a resounding yes.
Enter the —a term that has been generating significant buzz in clinical technology circles. While nomenclature can often be cryptic, this specific designation points to a next-generation device and software ecosystem designed to solve longstanding problems in source document verification (SDV) and remote patient monitoring.
Moreover, the 0900 series is the first portable iKey to pass the audit for clinical hardware, specifically addressing Annex A.8 (Asset Management) and A.13 (Communications Security). Comparing the "New" vs. Legacy iKey Prime Models For organizations debating an upgrade, here is a clear comparison:
While the industry waits for the final production model, forward-thinking CROs are already reserving their beta units. The message is clear: The era of messy, fragmented patient data is ending. The has arrived. Ready to learn more? Contact your clinical technology provider to request a demo unit of the iKey Prime Beta 0900 New and see how it can transform your next study’s data integrity.
Each site receives a starter kit containing 10 units of the iKey Prime Beta 0900 New . The setup process is QR-code based; a site administrator scans the device QR, assigns it to a specific patient ID, and the device auto-provisions.
Patients are given the key with a simple silicon sleeve. They pair it with their smartphone or home gateway. The "0900 New" features a simplified LED interface: Green for connected, Blue for syncing, Red for error. No complex menus.
For now, the is available for early-access partnerships. Sponsors who adopt the beta can expect a 40% reduction in data cleaning time before database lock (DBL). Conclusion: Is the iKey Prime Beta 0900 New Right for Your Next Trial? If you are managing a decentralized clinical trial (DCT) , a rare disease study requiring intensive home monitoring, or a Phase 3 cardiometabolic trial with thousands of data points per patient per day, the answer is a resounding yes.
Enter the —a term that has been generating significant buzz in clinical technology circles. While nomenclature can often be cryptic, this specific designation points to a next-generation device and software ecosystem designed to solve longstanding problems in source document verification (SDV) and remote patient monitoring. ikey prime beta 0900 new
Moreover, the 0900 series is the first portable iKey to pass the audit for clinical hardware, specifically addressing Annex A.8 (Asset Management) and A.13 (Communications Security). Comparing the "New" vs. Legacy iKey Prime Models For organizations debating an upgrade, here is a clear comparison: For now, the is available for early-access partnerships
While the industry waits for the final production model, forward-thinking CROs are already reserving their beta units. The message is clear: The era of messy, fragmented patient data is ending. The has arrived. Ready to learn more? Contact your clinical technology provider to request a demo unit of the iKey Prime Beta 0900 New and see how it can transform your next study’s data integrity. If you are managing a decentralized clinical trial
Each site receives a starter kit containing 10 units of the iKey Prime Beta 0900 New . The setup process is QR-code based; a site administrator scans the device QR, assigns it to a specific patient ID, and the device auto-provisions.
Patients are given the key with a simple silicon sleeve. They pair it with their smartphone or home gateway. The "0900 New" features a simplified LED interface: Green for connected, Blue for syncing, Red for error. No complex menus.